http://www.biotec.no/ http://www.biotec.no/news/patent-granted-in-usa-article665-18.html A composition patent protecting combinations of Biotec Pharmacon’s proprietary compound soluble yeast beta-glucan (SBG) as an adjuvant together with monoclonal antibodies for treatment of cancer has been granted in the U.S. Fri, 28 May 2010 12:50:17 +0200 http://www.biotec.no/financial-calendar/q1-2010-presentation-as-webcast-article663-175.html Biotec Phamacon will present its report for Q1 2010 on May 11th at 09:00. The presentation will be held at Thon Conference Vika Atrium, Oslo. The presentation will also be available as webcast. Thu, 29 Apr 2010 14:06:00 +0200 http://www.biotec.no/news/ordinary-general-meeting-article661-18.html The Board of Directors has today given notice of ordinary general meeting in Biotec Pharmacon to be held May 4th, 2010, at 15:00. The meeting will be held at the company's premises in Strandgata 3, Tromsø, Norway. Tue, 13 Apr 2010 15:00:38 +0200 http://www.biotec.no/news/biotec-marine-biochemicals-reviewed-in-pcr-insider-the-leading-journal-for-pcr-users-article659-18.html The review focuses on the strong technological platform of Biotec Marine Biochemicals and the obvious advantages the products offer to the customers. Focus is also given to the expansion of the product portfolio with products offering new solutions to the customers. A very strong customer statement puts the unique features of Biotec Marine Biochemicals - both regarding products and service into perspective. Fri, 09 Apr 2010 16:04:48 +0200 http://www.biotec.no/news/svein-lien-appointed-new-ceo-of-biotec-pharmacon-asa-article657-18.html Svein Lien has been appointed new CEO of Biotec Pharmacon, following Lars Viksmoen’s decision to resign after 3 years as CEO. Svein Lien will assume the position with effect from 15 March, 2010. Wed, 10 Mar 2010 14:33:03 +0100